Quest Diagnostics To Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology For Improving Personalized Cancer Care To Oncology Portfolio
Acquiring Company
Quest Diagnostics
Acquired Company
Haystack Oncology
SecaucusBaltimoreData And AnalyticsHealth CareBiotechnologyHealth CareMedicalDescription
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, and Haystack Oncology, an early-stage oncology company focused on minimal residual disease (MRD) testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisions, today announced a definitive agreement for Quest to acquire Haystack in an all-cash equity transaction.
Quick answer
Quest Diagnostics is acquiring Haystack Oncology, announced April 27, 2023. Quest Diagnostics is based in Secaucus, New Jersey, United States.
- How much did Quest Diagnostics pay for Haystack Oncology?
- The deal value was not disclosed.
- What does Quest Diagnostics do?
- Quest Diagnostics empowers people to take action to improve health outcomes.
- Where are Quest Diagnostics and Haystack Oncology based?
- Quest Diagnostics is based in Secaucus, New Jersey, United States. Haystack Oncology is based in Baltimore, Maryland, United States.
- Who are the decision-makers at Quest Diagnostics?
- Fundz holds 2 contacts at Quest Diagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Data And Analytics and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Shockwave Medical Completes Acquisition Of Neovasc (April 11, 2023)
- Sunmed To Acquire Avanos Medical’S Respiratory Health Business (June 8, 2023)
- Genesis Drug Discovery & Development (Gd3), A Member Of Genesis Global Group, Acquires Jss Medical Research To Expand Its Clinical Services Portfolio (May 10, 2023)
- Medical Specialists Of The Palm Beaches (Mspb) Acquires Cohen Medical Associates (May 2, 2023)
- Solmetex, Llc Acquires Impladent Ltd. (June 5, 2023)
- Abiogen Pharma Completes The Acquisition Of Effrx (May 29, 2023)
Who to call at Quest Diagnostics, and when
When Quest Diagnostics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Quest Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quest Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quest Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quest Diagnostics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Haystack Oncology?
Haystack Oncology was acquired by Quest Diagnostics, based in Secaucus. The deal was reported on April 27, 2023. Quest Diagnostics empowers people to take action to improve health outcomes. Quest Diagnostics is publicly traded (DGX) and operates in Data And Analytics.
When did Quest Diagnostics acquire Haystack Oncology?
Quest Diagnostics's acquisition of Haystack Oncology was reported on April 27, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Haystack Oncology do?
Make better decisions with better MRD testing Unmatched sensitivity and specificity for confident MRD detection. Arriving Soon. It is privately held, operating in Biotechnology, and is based in Baltimore.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.